awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q41643200-2E4B4A26-3C91-4523-B921-1D8F3138AB07
Q41643200-2E4B4A26-3C91-4523-B921-1D8F3138AB07
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41643200-2E4B4A26-3C91-4523-B921-1D8F3138AB07
Characterising and predicting bleeding in high-risk patients with an acute coronary syndrome.
P2860
Q41643200-2E4B4A26-3C91-4523-B921-1D8F3138AB07
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41643200-2E4B4A26-3C91-4523-B921-1D8F3138AB07
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3ba8a7a61c18143d63a5caef80387a1d02ba422f
P2860
Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial.